Literature DB >> 2937484

An assay for paracetamol, produced by the O-deethylation of phenacetin in vitro, using gas chromatography/electron capture negative ion chemical ionization mass spectrometry.

S Murray, A R Boobis.   

Abstract

A sensitive gas chromatographic/mass spectrometric assay for paracetamol, produced by the O-deethylation of phenacetin by microsomal fractions of human liver, has been developed. The method uses the 3,5-bistrifluoromethyl-benzoyl derivative of paracetamol and electron capture negative ion chemical ionization. This derivative has a negative ion mass spectrum which contains only a molecular ion at m/z 391 and, when this ion is specifically monitored, an amount of derivative equivalent to 1 pg of paracetamol can be detected. (2H3)Paracetamol was available for use as an internal standard and this allowed the development of an assay with a precision of 8% (SD) at 0.5 ng paracetamol per microsomal incubation and a lower limit of quantitative determination of 0.2 ng paracetamol per microsomal incubation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937484     DOI: 10.1002/bms.1200130208

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  5 in total

1.  Identification of a functionally conserved surface region of rat cytochromes P450IA.

Authors:  R J Edwards; A M Singleton; B P Murray; S Murray; A R Boobis; D S Davies
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

2.  A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.

Authors:  D Sesardic; A R Boobis; R J Edwards; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

3.  An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity.

Authors:  R J Edwards; A M Singleton; B P Murray; D Sesardic; K J Rich; D S Davies; A R Boobis
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

4.  Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.

Authors:  C J Speirs; S Murray; A R Boobis; C E Seddon; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

5.  Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

Authors:  D Sesardic; A R Boobis; B P Murray; S Murray; J Segura; R de la Torre; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.